Oxford Silk Phage Technologies Limited

In this project, OSPT is aiming to evaluate the feasibility of its technology integrating bacteriophage viruses, as an implantable bioactive textile device for cardiovascular applications. The device will be expected to reduce the risk of infections when using implants in cardiac surgery. Work will include the design and test of a first implantable protot...

Oxford Silk Phage Technologies (OSPT) is developing a disruptive platform technology using bacteriophages to actively prevent medical device and implant infections, a growing concern in the current context of global threatening antimicrobial resistance. Building upon its proof-of-concept work, OSPT will use its bacteriophage bio-textile technology to desi...

OSPT is developing a first of a kind silk-bacteriophage biomaterial for medical devices and implants, to reduce the risk of surgical site infections in patient populations most at risk. Medical device infections are the most devastating complications following surgical procedures, and the current standard of care involves treatment with antibiotics follow...